SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mason Barge who wrote (232)10/5/1998 10:59:00 PM
From: Thomas Kirwin   of 422
 
Double Digit Growth in Revenues and Net Income

Mason,

Ok, quick draw! You won this one.......

While we wait for the 10-Q to be filed this press release provides some insight into the potential of Immucor's earnings strength. This quarter's sales grew with very little help in the way of instrument placements. Immucor is evidently reaching critical mass in reagent sales. I eagerly await the promised sales updates, analyst coverage, followed by a surge in revenue as well as net income.

Now, I challenge you to another news duel!

Regards,

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News